Kristen K. Buck - 09 Jan 2023 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Role
EVP, R&D and CMO
Signature
James Nisco, Attorney-in-Fact for Kristen K. Buck
Issuer symbol
LSTA
Transactions as of
09 Jan 2023
Net transactions value
-$8,077
Form type
4
Filing time
11 Jan 2023, 15:03:09 UTC
Previous filing
02 Sep 2022
Next filing
05 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSTA Common Stock Award $0 +18,000 +88% $0.000000 38,482 09 Jan 2023 Direct F1, F2
transaction LSTA Common Stock Tax liability $6,441 -2,147 -5.6% $3.00 36,335 09 Jan 2023 Direct F2, F3
transaction LSTA Common Stock Tax liability $1,636 -512 -1.4% $3.20 35,823 10 Jan 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LSTA Stock Options (Right to Buy) Award $0 +9,000 $0.000000 9,000 09 Jan 2023 Common Stock 9,000 $3.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 18,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2 Includes 23,808 unvested restricted stock awards.
F3 Shares withheld as payment of a tax liability on vesting of restricted stock.
F4 Includes 22,733 unvested restricted stock awards.
F5 One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.